Questcor (QCOR) COO Cartt Reaffirms No Material Impact Expected on Aetna Acthar Decision
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Trade QCOR Now!
Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) COO Steve Cartt reaffirms that Aetna's (NYSE: AET) move on Acthcar won't have a material impact for the pharma.
Comments were made during the company's conference call Thursday following a bulletin issued by Aetna Wednesday on reimbursement issues with Acthar.
Shares of Questcor are up 13.4 percent, but having a tough time getting back above $30 today.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Comments were made during the company's conference call Thursday following a bulletin issued by Aetna Wednesday on reimbursement issues with Acthar.
Shares of Questcor are up 13.4 percent, but having a tough time getting back above $30 today.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)
- UPDATE: Intuitive Surgical (ISRG) Jury Reaches Positive Verdict in Robot Case; Shares Rise
Create E-mail Alert Related Categories
Conference Calls, FDA, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
